A detailed history of Altium Capital Management LP transactions in Kempharm, Inc stock. As of the latest transaction made, Altium Capital Management LP holds 1,700,000 shares of KMPH stock, worth $8.4 Million. This represents 2.96% of its overall portfolio holdings.

Number of Shares
1,700,000
Previous 1,162,416 46.25%
Holding current value
$8.4 Million
Previous $5.74 Million 46.26%
% of portfolio
2.96%
Previous 3.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
537,584 Added 46.25%
1,700,000 $8.4 Million
Q2 2024

Aug 14, 2024

BUY
N/A
820,955 Added 240.42%
1,162,416 $5.74 Million
Q1 2024

May 15, 2024

BUY
N/A
341,461 New
341,461 $1.69 Million

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.